Nu Skin Enterprises (NYSE:NUS) Releases FY 2025 Earnings Guidance

Key Points

• Nu Skin Enterprises has updated its FY 2025 earnings guidance, projecting earnings per share (EPS) of 1.150-1.350, surpassing the consensus estimate of 0.99, and revenue guidance of $1.5 billion-$1.6 billion.
• The company recently saw its stock decline by 4.2%, closing at $8.22, while insiders were actively trading, with one selling over 4,500 shares and another purchasing 6,500 shares.
• In a recent research report, analysts upgraded Nu Skin's stock rating from "hold" to "buy", indicating a positive outlook on the company's performance.

Nu Skin Enterprises (NYSE:NUS - Get Free Report) updated its FY 2025 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of 1.150-1.350 for the period, compared to the consensus estimate of 0.99. The company issued revenue guidance of $1.5 billion-$1.6 billion, compared to the consensus revenue estimate of $1.5 billion.

Analyst Ratings Changes

Separately, Wall Street Zen raised shares of Nu Skin Enterprises from a "hold" rating to a "buy" rating in a research report on Monday, May 12th.

Nu Skin Enterprises Stock Down 4.2%

NUS stock traded down $0.36 during trading on Thursday, hitting $8.22. 757,054 shares of the stock traded hands, compared to its average volume of 648,794. Nu Skin Enterprises has a 1 year low of $5.32 and a 1 year high of $10.88. The firm's 50 day moving average is $8.40 and its two-hundred day moving average is $7.45. The stock has a market cap of $406.00 million, a price-to-earnings ratio of -10.27 and a beta of 0.91. The company has a debt-to-equity ratio of 0.29, a current ratio of 2.02 and a quick ratio of 1.29.

Nu Skin Enterprises (NYSE:NUS - Get Free Report) last announced its quarterly earnings results on Thursday, August 7th. The company reported $0.43 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.25 by $0.18. Nu Skin Enterprises had a negative net margin of 2.30% and a positive return on equity of 6.99%. On average, sell-side analysts anticipate that Nu Skin Enterprises will post 1.05 EPS for the current year.

Nu Skin Enterprises Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Wednesday, June 11th. Stockholders of record on Friday, May 30th were paid a $0.06 dividend. The ex-dividend date was Friday, May 30th. This represents a $0.24 dividend on an annualized basis and a dividend yield of 2.9%. Nu Skin Enterprises's payout ratio is currently -30.00%.

Insider Buying and Selling

In other news, Director Edwina D. Woodbury sold 4,532 shares of Nu Skin Enterprises stock in a transaction that occurred on Monday, June 2nd. The shares were sold at an average price of $8.44, for a total value of $38,250.08. Following the completion of the sale, the director directly owned 42,947 shares in the company, valued at $362,472.68. The trade was a 9.55% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, insider Steven Keith Hatchett purchased 6,500 shares of Nu Skin Enterprises stock in a transaction dated Wednesday, May 28th. The stock was bought at an average price of $7.54 per share, with a total value of $49,010.00. Following the completion of the purchase, the insider directly owned 162,065 shares of the company's stock, valued at approximately $1,221,970.10. This trade represents a 4.18% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders own 2.00% of the company's stock.

Institutional Trading of Nu Skin Enterprises

A number of large investors have recently made changes to their positions in the stock. Amundi boosted its holdings in shares of Nu Skin Enterprises by 18.8% in the first quarter. Amundi now owns 18,564 shares of the company's stock worth $127,000 after buying an additional 2,941 shares during the last quarter. Dynamic Technology Lab Private Ltd bought a new stake in Nu Skin Enterprises during the first quarter valued at approximately $162,000. AQR Capital Management LLC grew its position in Nu Skin Enterprises by 64.6% during the first quarter. AQR Capital Management LLC now owns 350,357 shares of the company's stock valued at $2,530,000 after buying an additional 137,475 shares during the period. Finally, Goldman Sachs Group Inc. grew its position in Nu Skin Enterprises by 7.2% during the first quarter. Goldman Sachs Group Inc. now owns 1,319,885 shares of the company's stock valued at $9,582,000 after buying an additional 88,088 shares during the period. 82.84% of the stock is currently owned by institutional investors.

About Nu Skin Enterprises

Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.